XML 27 R16.htm IDEA: XBRL DOCUMENT v3.26.3
Subsequent Events
9 Months Ended
Sep. 30, 2026
Subsequent Events  
Subsequent Events

Note 10. Subsequent Events

The Company has further evaluated subsequent events for recognition and remeasurement purposes as of and for the nine months ended September 30, 2026. After review and evaluation, management has concluded that there were no material subsequent events as of the date that the financial statements were available to be issued, other than as disclosed below.

Modification of Two-Year Milestone Warrants

On November 2, 2026, the Company entered into an amendment (the “Warrant Amendment”) to its outstanding Two-Year Milestone Warrants to purchase common stock or pre-funded warrants issued in connection with the 2026 Offering with holders representing approximately 75% of the shares of common stock and 2026 Pre-Funded Warrants issuable under the Two-Year Milestone Warrants. The Two-Year Milestone Warrants are exercisable for shares of common stock or 2026 Pre-Funded Warrants in lieu thereof. Pursuant to the terms of those warrants, the Warrant Amendment is binding on all holders of outstanding Two-Year Milestone Warrants, whether or not a holder executed the amendment.

Effective November 2, 2026, the Warrant Amendment reduced the exercise price of the shares of common stock and 2026 Pre-Funded Warrants issuable upon exercise of the Two-Year Milestone Warrants from $0.3221 to $0.20 per share of common stock and from $0.3220 to $0.1999 per pre-funded warrant. The amendment did not modify the warrant share count or the accelerated November 16, 2026 expiration date.

The Warrant Amendment constitutes a modification of an equity-classified freestanding equity-linked instrument. The Company estimates the resulting increment, measured as the excess of the fair value of the Two-Year Milestone Warrants immediately after the Warrant Amendment over their fair value immediately before it, at approximately $3.1 million. The increment will be recognized within stockholders’ equity in the fourth quarter of 2026 and will have no effect on total stockholders’ equity.

Exercise of Two-Year Milestone Warrants

In connection with the Warrant Amendment, certain holders party thereto have agreed to exercise the Two-Year Milestone Warrants held by them at the reduced exercise price. The Company received approximately $6.2 million in gross proceeds from such exercises. If all 49,091,897 Two-Year Milestone Warrants outstanding as of September 30, 2026 were exercised for cash at the reduced exercise price, the Company would receive approximately $9.8 million in gross proceeds, including the proceeds expected from the exercises described above, although there can be no assurances that any additional Two-Year Milestone Warrants will be exercised. The condensed consolidated financial statements as of and for the period ended September 30, 2026 do not reflect the Warrant Amendment or any related exercises.